These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3416412)

  • 1. Hypocitraturia and its role in renal stone disease.
    Abdulhadi MH; Hall PM; Streem SB
    Cleve Clin J Med; 1988; 55(3):242-5. PubMed ID: 3416412
    [No Abstract]   [Full Text] [Related]  

  • 2. Urine citrate and renal stone disease.
    Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
    CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
    Pak CY; Fuller C
    Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
    Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
    Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrate and renal calculi: an update.
    Pak CY
    Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The problem of idiopathic stone formers presenting with no metabolic disorders. Pathogenesis and management.
    Pak CY
    Contrib Nephrol; 1987; 58():164-71. PubMed ID: 3319402
    [No Abstract]   [Full Text] [Related]  

  • 8. Citrate and renal calculi: new insights and future directions.
    Pak CY
    Am J Kidney Dis; 1991 Apr; 17(4):420-5. PubMed ID: 2008910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrate and renal calculi.
    Pak CY
    Miner Electrolyte Metab; 1987; 13(4):257-66. PubMed ID: 3306318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can citrate therapy prevent nephrolithiasis?
    Abdulhadi MH; Hall PM; Streem SB
    Urology; 1993 Mar; 41(3):221-4. PubMed ID: 8442301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
    Barcelo P; Wuhl O; Servitge E; Rousaud A; Pak CY
    J Urol; 1993 Dec; 150(6):1761-4. PubMed ID: 8230497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi].
    Hofbauer J; Höbarth K; Zechner O
    Z Urol Nephrol; 1990 Nov; 83(11):597-602. PubMed ID: 2100085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary citrate excretion in patients with renal calculi.
    Menon M; Mahle CJ
    J Urol; 1983 Jun; 129(6):1158-60. PubMed ID: 6854790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of Magurlit granulates].
    Frang D; Verebélyi A; Nagy Z
    Acta Chir Acad Sci Hung; 1978; 19(4):363-72. PubMed ID: 757918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Citrate (CG-120) therapy for urolithiasis. 1. Clinical effects].
    Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
    Hinyokika Kiyo; 1988 May; 34(5):905-17. PubMed ID: 3051945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graphic display of urinary risk factors for renal stone formation.
    Pak CY; Skurla C; Harvey J
    J Urol; 1985 Nov; 134(5):867-70. PubMed ID: 4057368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
    Preminger GM; Sakhaee K; Skurla C; Pak CY
    J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Citrate and kidney stones].
    Osther PJ
    Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatment of calcium calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):325-33. PubMed ID: 3576853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.